May 28, 2021

VIA EDGAR

Division of Corporation Finance

U.S. Securities & Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention:     Anna Abramson

 

        Re:    NantHealth, Inc.
   Registration Statement on Form S-3
   Filed May 26, 2021
   File No. 333-256474
   Acceleration Request
           Requested Date:            June 2, 2021
           Requested Time:    4:00 P.M. Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, NantHealth, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-256474) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, Professional Corporation, by calling Thomas Hornish at (850) 350-2392.

Sincerely,

 

NANTHEALTH, INC.

/s/ Bob Petrou

Bob Petrou
Chief Financial Officer

 

cc:

Brandon Villery, NantHealth, Inc.

Martin J. Waters, Wilson Sonsini Goodrich & Rosati, P.C.

Thomas Hornish, Wilson Sonsini Goodrich & Rosati, P.C.